1. Home
  2. VZLA vs ABCL Comparison

VZLA vs ABCL Comparison

Compare VZLA & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VZLA

Vizsla Silver Corp.

HOLD

Current Price

$3.41

Market Cap

1.1B

Sector

N/A

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.85

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VZLA
ABCL
Founded
2017
2012
Country
Canada
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
VZLA
ABCL
Price
$3.41
$3.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$7.00
$8.40
AVG Volume (30 Days)
7.3M
2.4M
Earning Date
12-12-2025
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.91
EPS
N/A
N/A
Revenue
N/A
$75,128,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$23.96
P/E Ratio
N/A
N/A
Revenue Growth
N/A
160.56
52 Week Low
$2.04
$1.94
52 Week High
$7.19
$6.52

Technical Indicators

Market Signals
Indicator
VZLA
ABCL
Relative Strength Index (RSI) 47.78 65.42
Support Level $2.88 $3.35
Resistance Level $3.48 $4.93
Average True Range (ATR) 0.17 0.16
MACD 0.07 0.05
Stochastic Oscillator 80.00 92.65

Price Performance

Historical Comparison
VZLA
ABCL

About VZLA Vizsla Silver Corp.

Vizsla Silver Corp is a junior mineral exploration and development company focused on advancing its Panuco silver-gold project located in Sinaloa, Mexico. The property contains quartz-carbonate veins with workings defining both steeply plunging and sub-horizontal ore shoots. Mineralization occurs as silver sulphides including argentite and acanthite, native gold, electrum and native silver associated with pyrite, minor galena, sphalerite and rare chalcopyrite. It has one operating segment, which is principally mineral exploration.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: